Across TCGA pan-cancer cohorts, MIR514A2 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR514A2 data layer compared with 1 for mutation status.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR514A2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR514A2 expression acts as an unfavorable survival marker.

STAD and SARC are the cancer types where MIR514A2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.215	0.676	.011	72	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR514A2 tumor-vs-normal RNA expression · all MIR514A2 data types